Foreword Editorial
| Authors: | Hyman, D. M.; Ladanyi, M. |
| Title: | Foreword |
| Keywords: | immunohistochemistry; signal transduction; unclassified drug; drug safety; drug approval; drug targeting; cancer patient; cancer diagnosis; protein function; protein analysis; editorial; drug potency; food and drug administration; protein tyrosine kinase; cancer research; central nervous system; protein tyrosine kinase inhibitor; fluorescence in situ hybridization; dna sequence; rna sequence; fusion protein; next generation sequencing; tropomyosin; priority journal; entrectinib; malignant neoplasm; larotrectinib; selitrectinib; neurotrophic tropomyosin receptor kinase 1; repotrectinib; tropomyosin receptor; tropomyosin receptor kinase fusion; tropomyosin receptor kinase inhibitor |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 8 |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-11-01 |
| Start Page: | viii1 |
| End Page: | viii2 |
| Language: | English |
| DOI: | 10.1093/annonc/mdz409 |
| PROVIDER: | scopus |
| PMCID: | PMC6859812 |
| PUBMED: | 32223933 |
| DOI/URL: | |
| Notes: | Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
